These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2399887)
21. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans. Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998 [TBL] [Abstract][Full Text] [Related]
22. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983 [TBL] [Abstract][Full Text] [Related]
23. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia. Man KC; Williamson BD; Niebauer M; Daoud E; Bakr O; Strickberger SA; Hummel JD; Kou W; Morady F Am J Cardiol; 1994 Dec; 74(11):1119-23. PubMed ID: 7977070 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide. Windle J; Prystowsky EN; Miles WM; Heger JJ Clin Pharmacol Ther; 1987 Jun; 41(6):603-10. PubMed ID: 3581646 [TBL] [Abstract][Full Text] [Related]
25. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease. Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220 [TBL] [Abstract][Full Text] [Related]
26. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease. Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488 [TBL] [Abstract][Full Text] [Related]
27. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment. Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387 [TBL] [Abstract][Full Text] [Related]
28. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy. Rae AP; Sokoloff NM; Webb CR; Spielman SR; Greenspan AM; Horowitz LN J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928 [TBL] [Abstract][Full Text] [Related]
29. Termination of ventricular tachycardia: role of tachycardia cycle length. Roy D; Waxman HL; Buxton AE; Marchlinski FE; Cain ME; Gardner MJ; Josephson ME Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712 [TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone. Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883 [TBL] [Abstract][Full Text] [Related]
31. Amiodarone therapy: role of early and late electrophysiologic studies. Greenspon AJ; Volosin KJ; Greenberg RM; Jefferies L; Rotmensch HH J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688 [TBL] [Abstract][Full Text] [Related]
32. Procainamide induced sustained monomorphic ventricular tachycardia in a patient with benign premature ventricular complexes. Bhandari AK; Au PK; Rahimtoola SH Can J Cardiol; 1986; 2(1):6-9. PubMed ID: 2420424 [TBL] [Abstract][Full Text] [Related]
33. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia. Marchlinski FE; Buxton AE; Miller JM; Vassallo JA; Flores BT; Josephson ME Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease. Pires LA; Wagshal AB; Greene TO; Mittleman RS; Huang SK Am J Cardiol; 1993 Oct; 72(12):908-10. PubMed ID: 8105674 [TBL] [Abstract][Full Text] [Related]
35. Amiodarone: correlation of early and late electrophysiologic studies with outcome. Kadish AH; Marchlinski FE; Josephson ME; Buxton AE Am Heart J; 1986 Dec; 112(6):1134-40. PubMed ID: 3788759 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction. Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW Am Heart J; 1989 Oct; 118(4):702-8. PubMed ID: 2801477 [TBL] [Abstract][Full Text] [Related]
37. Verapamil in ventricular tachycardia. Hasin Y; Kriwisky M; Gotsman MS Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466 [TBL] [Abstract][Full Text] [Related]